Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women.

Saved in:

Bibliographic Details
Title:	Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women.
Authors:	Gupta N; Department of Radiation Oncology, Government Medical College and Hospital, Chandigarh, India., Gupta D; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Dixit J; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Mehra N; Department of Medical Oncology, Adyar Cancer Institute, Chennai, Tamil Nadu, India., Singh A; Department of Medical Oncology, Christian Medical College, Vellore, Tamil Nadu, India., Krishnamurthy MN; Department of Clinical Pharmacology, Tata Memorial Centre, Mumbai, Maharashtra, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Jyani G; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Rajsekhar K; Department of Health Research, Ministry of Health and Family Welfare, New Delhi, India., Kalaiyarasi JP; Department of Medical Oncology, Adyar Cancer Institute, Chennai, Tamil Nadu, India., Roy PS; Department of Medical Oncology, Dr. B. Booroah Cancer Institute, Guwahati, Assam, India., Malik PS; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Mathew A; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Malhotra P; Department of Internal Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Gupta S; Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Kumar L; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Kataki A; Department of Gynaecologic Oncology, Dr. B. Booroah Cancer Institute, Guwahati, Assam, India., Prinja S; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. shankarprinja@gmail.com.
Source:	Applied health economics and health policy [Appl Health Econ Health Policy] 2022 Jul; Vol. 20 (4), pp. 609-621. Date of Electronic Publication: 2022 May 10.
Publication Type:	Journal Article
Journal Info:	Publisher: Open Mind Journals Ltd Country of Publication: New Zealand NLM ID: 101150314 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1896 (Electronic) Linking ISSN: 11755652 NLM ISO Abbreviation: Appl Health Econ Health Policy Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1179-1896
DOI:	10.1007/s40258-022-00731-2